HG-1224

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameHG-1224

Drug Alias NameBSF3 modulator (Human Genome Sciences)CLCF1 modulator (Human Genome Sciences)cardiotrophin-like cytokine factor 1 modulator (Human Genome Sciences)B-cell stimulating factor 3 modulator (Human Genome Sciences)CLC modulator (Human Genome Sciences) +[7]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionB-cell activating factor receptor modulators

TargetsB-cell activating factor receptor

Therapy Area/IndicationsImmune System DiseasesNervous System Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHuman Genome Sciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHuman Genome Sciences Inc

Active IndicationsN/A

Inactive IndicationsImmune System DiseasesNervous System Diseases

Other Information

ATC CodeN/A